Torthaí cuardaigh - J.-P. Devogelaer

  • 1 - 17 toradh as 17 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass.

    Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass. de réir J.-P. Devogelaer, J Crabbé, C Nagant de Deuxchaisnes

    Foilsithe / Cruthaithe 1987
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Primary Prevention of Glucocorticoid-Induced Osteoporosis with Intravenous Pamidronate and Calcium: A Prospective Controlled 1-Year Study Comparing a Single Infusion, an Infusion Given Once Every 3 Months, and Calcium Alone

    Primary Prevention of Glucocorticoid-Induced Osteoporosis with Intravenous Pamidronate and Calcium: A Prospective Controlled 1-Year Study Comparing a Single Infusion, an Infusion G... de réir Y. Boutsen, Jacques Jamart, W. Esselinckx, J.-P. Devogelaer

    Foilsithe / Cruthaithe 2001
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Loading and Skeletal Development and Maintenance

    Loading and Skeletal Development and Maintenance de réir P. Bergmann, Jean‐Jacques Body, S. Boonen, Y. Boutsen, J.-P. Devogelaer, Stefan Goemaere, JM Kaufman, Jean‐Yves Reginster, Serge Rozenberg

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club

    Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of t... de réir P. Bergmann, J.J. Body, Steven Boonen, Y. Boutsen, J. P. Devogelaer, Stefan Goemaere, Jean M. Kaufman, J.-Y. Reginster, Valérie Gangji

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Management of osteoporosis in the elderly

    Management of osteoporosis in the elderly de réir René Rizzoli, Olivier Bruyère, Jorge B. Cannata‐Andía, J. P. Devogelaer, George P. Lyritis, J. D. Ringe, Bruno Vellas, J.-Y. Reginster

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications

    Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications de réir J.J. Body, Pierre Bergmann, Steven Boonen, J.-P. Devogelaer, Evelien Gielen, Stefan Goemaere, Jean‐Marc Kaufman, Serge Rozenberg, J.-Y. Reginster

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club

    Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club de réir J.J. Body, P. Bergmann, Steven Boonen, Y. Boutsen, J.-P. Devogelaer, Stefan Goemaere, Jean‐Marc Kaufman, Serge Rozenberg, J.-Y. Reginster

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Safety and Efficacy of a Novel Salmon Calcitonin (sCT) Technology-Based Oral Formulation in Healthy Postmenopausal Women: Acute and 3-Month Effects on Biomarkers of Bone Turnover

    Safety and Efficacy of a Novel Salmon Calcitonin (sCT) Technology-Based Oral Formulation in Healthy Postmenopausal Women: Acute and 3-Month Effects on Biomarkers of Bone Turnover de réir László B. Tankó, Yu Z. Bagger, Peter Alexandersen, J.-P. Devogelaer, Jean‐Yves Reginster, Rosalind Chick, Melvin Olson, Hakim Benmammar, Linda Mindeholm, M. Azria, Claus Christiansen

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club

    Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club de réir Jean‐Jacques Body, P. Bergmann, S. Boonen, Y. Boutsen, Olivier Bruyère, J.-P. Devogelaer, Stefan Goemaere, Nadine Hollevoet, Jean‐Marc Kaufman, Koen Milisen, Serge Rozenberg, J.-Y. Reginster

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study

    Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study de réir Jean‐Yves Reginster, Ego Seeman, M.C. de Vernejoul, S. Adámi, Juliet Compston, C. Phenekos, J.-P. Devogelaer, Díaz Curiel M, A. Sawicki, Stefan Goemaere, O. H. Sørensen, Dieter Felsenberg, Pierre J. Meunier

    Foilsithe / Cruthaithe 2005
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis

    Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis de réir J-Y. Reginster, J.-M. Kaufman, Stefan Goemaere, J.-P. Devogelaer, C.L. Benhamou, Dieter Felsenberg, Díaz Curiel M, Maria Luisa Brandi, J Badurski, John D. Wark, Á. Balogh, Olivier Bruyère, Christian Roux

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Management of Glucocorticoid-Induced Osteoporosis

    Management of Glucocorticoid-Induced Osteoporosis de réir René Rizzoli, Jonathan D. Adachi, Cyrus Cooper, W. Dere, J. P. Devogelaer, Adolfo Díez‐Pérez, John А. Kanis, Andrea Laslop, Bruce Mitlak, Socrates E. Papapoulos, SH Ralston, S. Reiter, G. Werhya, Jean‐Yves Reginster

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement

    Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections abou... de réir J.-Y. Reginster, S Reiter-Niesert, Olivier Bruyère, Françis Berenbaum, Maria Luisa Brandi, Jaime Branco, J.-P. Devogelaer, Gabriel Herrero‐Beaumont, John А. Kanis, Stefania Maggi, E. Maheu, Pascal Richette, René Rizzoli, Cyrus Cooper

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Treatment of osteoporosis in men

    Treatment of osteoporosis in men de réir JM Kaufman, J.-Y. Reginster, Steven Boonen, Maria Luisa Brandi, Cyrus Cooper, W. Dere, J.-P. Devogelaer, Adolfo Díez‐Pérez, John А. Kanis, E. McCloskey, Bruce Mitlak, Eric Orwoll, J. D. Ringe, G. Weryha, René Rizzoli

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis

    Recommendations for the use of new methods to assess the efficacy of disease-modifying drugs in the treatment of osteoarthritis de réir Éric Abadie, D Ethgen, Bernard Avouac, G Bouvenot, Jaime Branco, Olivier Bruyère, Gonzalo Calvo, J.-P. Devogelaer, R.-L. Dreiser, Gabriel Herrero‐Beaumont, André Kahan, G. Kreutz, Andrea Laslop, Ernst Martin Lemmel, George Nuki, Leo van de Putte, L. Vanhaelst, Jean‐Yves Reginster

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis

    Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis de réir Robin Altman, Éric Abadie, Bernard Avouac, G Bouvenot, Jaime Branco, Olivier Bruyère, Gonzalo Calvo, J.-P. Devogelaer, R.-L. Dreiser, Gabriel Herrero‐Beaumont, André Kahan, G. Kreutz, Andrea Laslop, Ernst Martin Lemmel, C J Menkès, Karel Pavelká, Leo van de Putte, L. Vanhaelst, Jean‐Yves Reginster

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density

    Intravenous Zoledronic Acid in Postmenopausal Women with Low Bone Mineral Density de réir Ian R. Reid, Jacques P. Brown, P. Burckhardt, Zebulun D. Horowitz, Peter Richardson, U. Trechsel, A. Widmer, J.-P. Devogelaer, Jean‐Marc Kaufman, Philippe Jaeger, Jean-Jacques Body, Maria Luisa Brandi, Johann Broell, Raffaele Di Micco, Andrea Riccardo Genazzani, Dieter Felsenberg, J. Happ, Michael Hooper, Jochen Ittner, G. Leb, Hans Mallmin, Timothy M. Murray, S. Ortolani, Alessandro Rubinacci, Maria Sääf, Göran Samsioe, Leon Verbruggen, Pierre J. Meunier

    Foilsithe / Cruthaithe 2002
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: